Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 219

Results For "LTI"

2708 News Found

Uniphore and SpinSci join hands to improve patient access and engagement
Digitisation | March 15, 2022

Uniphore and SpinSci join hands to improve patient access and engagement

Deploying solutions like Uniphore’s U-Self Serve and U-Assist with SpinSci’s Patient Engage and Patient Assist is an important step forward in creating frictionless patient experiences


IHH Healthcare India appoints Biju Nair as COO of Bengaluru cluster
People | March 15, 2022

IHH Healthcare India appoints Biju Nair as COO of Bengaluru cluster

He has over 25 years of rich experience in marketing and business in various sectors


Illumina unveils pathbreaking genomic profiling test for cancer in Europe
Medical Device | March 15, 2022

Illumina unveils pathbreaking genomic profiling test for cancer in Europe

The single in vitro diagnostic test helps inform therapy decisions according to clinical guidelines to enable precision medicine earlier in the disease journey


Spectrum Chemical launches products for vaccines, therapeutics and biopharmaceuticals
Biotech | March 15, 2022

Spectrum Chemical launches products for vaccines, therapeutics and biopharmaceuticals

A growing portfolio of chemicals is part of a larger quality management system that sets new standards in bioprocessing


Ascletis increases ritonavir production capacity to 530 million tablets a year
Biotech | March 14, 2022

Ascletis increases ritonavir production capacity to 530 million tablets a year

Ritonavir oral tablet is a pharmacokinetic booster of multiple oral antiviral drugs targeting viral proteases and a component of the approved oral antiviral drug Paxlovid (Nirmatrelvir 300 mg tablet + ritonavir 100 mg tablet co-administration package)


Moderna dosed the first participant for an experimental HIV trimer mRNA vaccine
News | March 14, 2022

Moderna dosed the first participant for an experimental HIV trimer mRNA vaccine

The open-label, multicenter, randomized Phase 1 trial is designed to evaluate the safety and immunogenicity of experimental HIV trimer mRNA vaccines


Draft policy on medical devices released
Policy | March 14, 2022

Draft policy on medical devices released

Feedback and remarks of the industry and stakeholders are invited till the 25th of March 2022


USFDA clears Niramai's breast thermography device
News | March 14, 2022

USFDA clears Niramai's breast thermography device

The SMILE-100 System is a breast thermography device that helps healthcare personnel review, measure and analyze thermally significant indications in the breast region


Adlarity receives USFDA approval for treatment of Alzheimer
Drug Approval | March 14, 2022

Adlarity receives USFDA approval for treatment of Alzheimer

First and only once-weekly patch for convenient, well-tolerated delivery of most used drug for the treatment of Alzheimer's-related dementia


Japan tops CPhI ‘API Quality’ ranking for second year
News | March 13, 2022

Japan tops CPhI ‘API Quality’ ranking for second year

Digital meetings driving international partnering at CPhI Japan as companies search for ingredients suppliers